ScholarLens Back to search
2014•Expert Review of Anticancer TherapyRequires access

Optimal management of squamous cell carcinoma of the anal canal: where are we now?

Cathy Eng, Shahab U. Ahmed

Open publisher page 7 citations

Abstract

Anal cancer is an uncommon gastrointestinal tract malignancy rising in incidence annually for the past 5 years. Though subdivided into perianal and anal canal cancers, squamous cell carcinoma (SCCA) is the major variant. High risk HPV are associated with most SCCA. It is also evident that SCCA of the anal canal is highly prevalent in HIV+ patients. Over the past few decades, few studies have been conducted on anal cancers to describe the progress of basic and clinical research regarding SCCA of the anal canal. In this article, the discussion has been focused on the recent clinical developments and optimal recommendations for the management of SCCA of the anal canal, including anal cancer screening based on currently available data.

About this research paper

What this paper is about

Anal cancer is an uncommon gastrointestinal tract malignancy rising in incidence annually for the past 5 years. Though subdivided into perianal and anal canal cancers, squamous cell carcinoma (SCCA) is the major variant. High risk HPV are associated with most SCCA. It is also evident that SCCA of the anal canal is highly prevalent in HIV+ patients. Over the past few decades, few studies have been conducted on anal cancers to describe the progress of basic and clinical research regarding SCCA of the anal canal. In this article, the discussion has been focused on the recent clinical developments and optimal recommendations for the management of SCCA of the anal canal, including anal cancer screening based on currently available data.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Anal cancer is an uncommon gastrointestinal tract malignancy rising in incidence annually for the past 5 years. Though subdivided into perianal and anal canal cancers, squamous cell carcinoma (SCCA) is the major variant. High risk HPV are associated with most SCCA. It is also evident that SCCA of the anal canal is highly prevalent in HIV+ patients. Over the past few decades, few studies have been conducted on anal cancers to describe the progress of basic and clinical research regarding SCCA of the anal canal. In this article, the discussion has been focused on the recent clinical developments and optimal recommendations for the management of SCCA of the anal canal, including anal cancer screening based on currently available data.

Key concepts: Medicine, Anal canal, Anal cancer, Malignancy, Basal cell, Incidence (geometry), Cancer, Oncology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Optimal management of squamous cell carcinoma of the anal canal: where are we now? — Research Paper | ScholarLens